158 related articles for article (PubMed ID: 20414019)
21. Phase II trial on neoadjuvant intravenous and trans-uterine arterial chemotherapy for locally advanced bulky cervical adenocarcinoma.
Tsubamoto H; Maeda H; Kanazawa R; Ito Y; Ohama N; Hori M; Ikeda Y; Kato T; Sakane R; Hirota S
Gynecol Oncol; 2013 Apr; 129(1):129-34. PubMed ID: 23333929
[TBL] [Abstract][Full Text] [Related]
22. Neoadjuvant treatment of locally advanced carcinoma of the uterine cervix with epirubicin, paclitaxel and cisplatin.
D'Agostino G; Distefano M; Greggi S; Salerno M; Ferrandina G; Poerio A; Mancuso S; Scambia G
Cancer Chemother Pharmacol; 2002 Mar; 49(3):256-60. PubMed ID: 11935219
[TBL] [Abstract][Full Text] [Related]
23. [A pilot study of irinotecan hydrochloride(CPT-11)and cisplatin(CDDP)combination chemotherapy for previously treated non-small cell lung cancer].
Tanaka A; Aragane N; Komiya K; Kawaura F; Fukuno Y; Hayashi S
Gan To Kagaku Ryoho; 2008 Jan; 35(1):49-53. PubMed ID: 18195527
[TBL] [Abstract][Full Text] [Related]
24. Weekly irinotecan and cisplatin in advanced non-small cell lung cancer: a multicenter phase II study.
Jagasia MH; Langer CJ; Johnson DH; Yunus F; Rodgers JS; Schlabach LL; Cohen AG; Shyr Y; Carbone DP; Devore RF
Clin Cancer Res; 2001 Jan; 7(1):68-73. PubMed ID: 11205920
[TBL] [Abstract][Full Text] [Related]
25. [Neoadjuvant chemotherapy with paclitaxel and cisplantin or carboplatin for patients with locally advanced uterine cervical cancer].
Zhang R; Li B; Bai P; Li HJ; Li SM; Wu LY; Li W
Zhonghua Zhong Liu Za Zhi; 2011 Aug; 33(8):616-20. PubMed ID: 22325224
[TBL] [Abstract][Full Text] [Related]
26. Neoadjuvant chemotherapy for patients younger than 50 years with high-risk squamous cell carcinoma of the cervix.
Aoki Y; Tomita M; Sato T; Watanabe M; Kase H; Fujita K; Kurata H; Tanaka K
Gynecol Oncol; 2001 Nov; 83(2):263-7. PubMed ID: 11606081
[TBL] [Abstract][Full Text] [Related]
27. [Combined irinotecan (CPT-11) and nedaplatin (254-S) therapy for advanced and/or recurrent cervical cancer].
Hiruma R; Kamide T; Anzai N; Matsumoto R; Kotake Y; Wachi T; Shinozaki H; Tada A; Kamiya N; Sasaki H
Gan To Kagaku Ryoho; 2008 Apr; 35(4):607-10. PubMed ID: 18408429
[TBL] [Abstract][Full Text] [Related]
28. Phase II study of irinotecan combined with mitomycin-C for advanced or recurrent squamous cell carcinoma of the uterine cervix: the JGOG study.
Umesaki N; Fujii T; Nishimura R; Tanaka T; Nishida M; Fushiki H; Takizawa K; Yamamoto K; Hasegawa K; Izumi R;
Gynecol Oncol; 2004 Oct; 95(1):127-32. PubMed ID: 15385121
[TBL] [Abstract][Full Text] [Related]
29. Multi-institutional phase II study of neoadjuvant irinotecan and nedaplatin followed by radical hysterectomy and the adjuvant chemotherapy for locally advanced, bulky uterine cervical cancer: A Kansai Clinical Oncology Group study (KCOG-G1201).
Mori T; Makino H; Okubo T; Fujiwara Y; Sawada M; Kuroboshi H; Tsubamoto H; Murakoshi H; Motohashi T; Kitawaki J; Ito K
J Obstet Gynaecol Res; 2019 Mar; 45(3):671-678. PubMed ID: 30575239
[TBL] [Abstract][Full Text] [Related]
30. [Clinical effects of combination chemotherapy with irinotecan hydrochloride and cisplatin on cervical cancer: study of 46 patients].
Wang CY; Ma D; Zhu T; Chen SY; Zhang QH; Song XJ; Chen TH; Gu MJ
Zhonghua Yi Xue Za Zhi; 2005 Aug; 85(30):2104-8. PubMed ID: 16313818
[TBL] [Abstract][Full Text] [Related]
31. Dose-Dense Neoadjuvant Chemotherapy plus Radical Surgery in Locally Advanced Cervical Cancer: A Phase II Study.
Benedetti Panici P; Palaia I; Marchetti C; Ruscito I; Fischetti M; Musella A; Di Donato V; Perniola G; Vertechy L; Muzii L
Oncology; 2015; 89(2):103-10. PubMed ID: 25924602
[TBL] [Abstract][Full Text] [Related]
32. Phase II study of concurrent chemoradiotherapy with weekly cisplatin and paclitaxel in patients with locally advanced uterine cervical cancer: The JACCRO GY-01 trial.
Umayahara K; Takekuma M; Hirashima Y; Noda SE; Ohno T; Miyagi E; Hirahara F; Hirata E; Kondo E; Tabata T; Nagai Y; Aoki Y; Wakatsuki M; Takeuchi M; Toita T; Takeshima N; Takizawa K
Gynecol Oncol; 2016 Feb; 140(2):253-8. PubMed ID: 26701414
[TBL] [Abstract][Full Text] [Related]
33. Phase II trial of neoadjuvant paclitaxel and cisplatin in uterine cervical cancer.
Park DC; Kim JH; Lew YO; Kim DH; Namkoong SE
Gynecol Oncol; 2004 Jan; 92(1):59-63. PubMed ID: 14751139
[TBL] [Abstract][Full Text] [Related]
34. [Efficacy of low-dose CDDP and CPT-11 for patients with intestinal type of gastric adenocarcinoma].
Nagahori Y; Nagahori K; Hamaguchi Y; Fukushima T; Masui H; Mogaki M; Abe T
Gan To Kagaku Ryoho; 2008 Sep; 35(9):1555-9. PubMed ID: 18799911
[TBL] [Abstract][Full Text] [Related]
35. Neoadjuvant irinotecan, cisplatin, and concurrent radiation therapy with celecoxib for patients with locally advanced esophageal cancer.
Cleary JM; Mamon HJ; Szymonifka J; Bueno R; Choi N; Donahue DM; Fidias PM; Gaissert HA; Jaklitsch MT; Kulke MH; Lynch TP; Mentzer SJ; Meyerhardt JA; Swanson RS; Wain J; Fuchs CS; Enzinger PC
BMC Cancer; 2016 Jul; 16():468. PubMed ID: 27412386
[TBL] [Abstract][Full Text] [Related]
36. Paclitaxel, epirubicin, and cisplatin (TEP) regimen as neoadjuvant treatment in locally advanced cervical cancer: long-term results.
Ferrandina G; Distefano MG; De Vincenzo R; Salutari V; Petrillo M; Scarciglia ML; Pietragalla A; Conte C; Scambia G
Gynecol Oncol; 2013 Mar; 128(3):518-23. PubMed ID: 23237767
[TBL] [Abstract][Full Text] [Related]
37. Clinical efficacy of modified preoperative neoadjuvant chemotherapy in the treatment of locally advanced (stage IB2 to IIB) cervical cancer: randomized study.
Chen H; Liang C; Zhang L; Huang S; Wu X
Gynecol Oncol; 2008 Sep; 110(3):308-15. PubMed ID: 18606439
[TBL] [Abstract][Full Text] [Related]
38. [Clinical efficacy and safety of CPT-11+CDDP therapy as third-line chemotherapy for advanced and recurrent gastric cancer].
Godai TI; Oshima T; Numata M; Fukahori M; Sato T; Makino H; Fujii S; Rino Y; Masuda M; Imada T; Kunisaki C
Gan To Kagaku Ryoho; 2011 Jun; 38(6):945-9. PubMed ID: 21677484
[TBL] [Abstract][Full Text] [Related]
39. The toxicity and long-term efficacy of nedaplatin and paclitaxel treatment as neoadjuvant chemotherapy for locally advanced cervical cancer.
Yin M; Zhang H; Li H; Li X; Liu Y; Chen X; Lou G; Li K
J Surg Oncol; 2012 Feb; 105(2):206-11. PubMed ID: 21815150
[TBL] [Abstract][Full Text] [Related]
40. Feasibility study on combination chemotherapy using nogitecan hydrochloride (topotecan) and cisplatin for patients with metastatic, persistent, or recurrent uterine cervical cancer.
Shimada M; Sato S; Oishi T; Itamochi H; Kigawa J; Takeshima N; Aoki D; Aoki Y; Nambu Y; Ochiai K
Int J Clin Oncol; 2016 Oct; 21(5):969-974. PubMed ID: 27142771
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
